Regarding the eIF3 complex, significantly higher protein expression in gliomas compared to CCBT was detected for eIF3B (III: p < 0.05; Figure 2B), eIF3D (I: p < 0.05; III: p < 0.05; Figure S1F), eIF3H (III: p < 0.05; Figure S1G), eIF3I (I: p < 0.05, III: p < 0.001, IV: p < 0.01; Figure 2C) and eIF3M (III: p < 0.01; Figure S1I). This evidence concerns the gene EIF3M and central nervous system cancer.